Michael Schweizer, M.D.

Michael Schweizer M.D.
faculty member

Michael Schweizer, M.D.

Associate Member
Clinical Research Division, Fred Hutch

Fax: 206.606.2042
Mailstop: G6-075

Dr. Michael Schweizer is an oncologist who specializes in treating patients with bladder, prostate and testicular cancers. His research focuses on developing new drugs and therapies to treat these cancers and to help speed advances from the lab into the clinic. He leads a number of innovative translational clinical trials, including studies evaluating high-dose testosterone as a therapeutic option for men with advanced prostate cancer.

Other Appointments & Affiliations

Assistant Professor, Oncology
University of Washington School of Medicine

Education

M.D., Temple University School of Medicine, 2008

B.S., Chemical Engineering, University of Delaware, 2004

Research Interests

Translational prostate cancer research

Novel therapeutics/drug development

Dr. Schweizer in the News

‘Good cancer’? Views vary on a sunny phrase

Hutch News - November 10, 2016

For the Media

The Media Relations team at Fred Hutch is available to assist members of the news media who would like to arrange interviews with faculty.

Email media@fredhutch.org or call 206.667.2210.